依泽替米贝; 依折麦布; CAS 163222-33-1; 异构体; 代谢产物; 杂质

依泽替米贝; 依折麦布; CAS 163222-33-1; 异构体; 代谢产物; 杂质 中文名称：1-(4-氟苯基)-(3R)-[3-(4-氟苯基)-(3S)-羟基丙基]-(4S)-(4-羟基苯基)-2-丙内酰胺 英文名称：Ezetimibe; 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxy-propyl] -4-(4-hydroxyphenyl)-azetidin-2-one CAS 号：163222-33-1 含量标准：99% HPLC 其他相关: 1) 依折麦布,依泽替米贝异构体,7种. 2) 依折麦布,依泽替米贝代谢产物. 3)依折麦布,依泽替米贝工艺杂质. 依泽替米贝中间体; 依折麦布中间体; CAS 190595-65-4 中文名称：1-(4-氟苯基)-(3R)-[3-(4-氟苯基)-(3S)-羟基丙基]-(4S)-(4-羟基苯基)-2-丙内酰胺 英文名称：Ezetimibe intermediate; (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3 -[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one CAS 号：190595-65-4 含量标准：98% HPLC

We are offering three key services for new drug application, a. Mature(repeatable) pilot process with independent intellectual property rights; b. High purity sample designed for pharm companies; c. Impurity study. Our main products are Ulipristal acetate intermediates &impurities; Alogliptin benzoate intermediates, impurities &metabolin; Ezetimibe intermediates &impurities; Abiraterone Acetate; Dienogest; Tenofovir disoproxil fumarate & its intermediates; Bortezomib; Cabazitaxel; Lacosamide intermediates; Minodronic acid.